Generic Name and Formulations:
Ciprofloxacin 6% (60mg/mL); otic susp; preservative-free.
Indications for OTIPRIO:
Bilateral otitis media with effusion undergoing tympanostomy tube placement. Acute otitis externa due to P. aeruginosa and S. aureus.
Adults and Children:
<6mos: not established. For intratympanic or otic administration only. ≥6mos: Otitis media: give as one 0.1mL (6mg) single dose into each affected ear, following suctioning of middle ear effusion. Otitis externa: give as one 0.2mL (12mg) single dose to the external ear canal of each affected ear.
Potential for microbial overgrowth (eg, bacteria, fungi); if infections occur, use alternatives. Pregnancy.
Nasopharyngitis, irritability, ear pruritus, headache, otitis media, ear discomfort.
Single-patient use vial—1mL
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Improving Performance of Everyday Activities Is Critical in Schizophrenia
- Analysis Finds Lithium Maintenance Most Effective as Monotherapy in Bipolar Disorder
- Web-Based Intervention Targets Parental Behaviors That May Affect Adolescent Anxiety, Depression
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Examining Associations Between Diabetes and Effects on Cognition
- Untreated Depression Common in Women of Childbearing Age
- Incidence of Psychiatric Disorders in Rheumatoid Arthritis
- Effect of Antidepressant Class, Dose on Pediatric Anxiety Disorders